Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Unichem Laboratories Ltd - 506690 - Board Meeting Intimation for To Approve Audited Results (Standalone And Consolidated ) For The Year Ended March 31, 2021 And Recommendation Of Final Dividend, If Any.

 UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2021 ,inter alia, to consider and approve To approve Audited Results (Standalone and Consolidated ) for the year ended March 31, 2021 and recommendation of Final Dividend, if any.
21-05-2021

Unichem Labs gets USFDA nod to market generic antidepressant tablets

 Drug firm Unichem Laboratories on Thursday said it has received approval from the US health regulator to market generic Amitriptyline HCl tablets used in the treatment of depression. The company has received abbreviated new drug application (ANDA) approval to market its Amitriptyline HCl tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a regulatory filing. The product is a generic version of AstraZeneca Pharmaceuticals LP's Elavil tablets in the same strengths, it added. The tablets will be commercialised from the company's Goa plant, Unichem Labs said. Amitriptyline HCl Tablets are indicated for the relief of symptoms of depression, it added. Shares of Unichem Laboratories closed at Rs 358.60 per scrip on BSE, up 7.43 per cent from its previous close.
20-05-2021
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Amitriptyline HCl Tablets USP.
20-05-2021
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Advertisement Published in Newspapers regarding Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account.
19-05-2021
Bigul

Unichem Laboratories Ltd - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Advertisement Published in Newspapers regarding Notice for transfer of Equity Shares and Unclaimed Dividend to the Investor Education and Protection Fund (IEPF) Account.
19-05-2021
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Compliance under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.-Company has issued a Duplicate Share Certificate on May 17, 2021 in lieu of the original Share Certificates reported lost/misplaced.
19-05-2021
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
14-05-2021
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
04-05-2021
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspapers publication in namely Business Standard and Sakal regarding the Notice of Postal Ballot and e-Voting.
28-04-2021
Bigul

Unichem Laboratories Ltd - 506690 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Intimation of postal Ballot Notice.
27-04-2021
Next Page
Close

Let's Open Free Demat Account